Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension

Journal of Hypertension
Jens JordanNick Finer

Abstract

Obese patients are prone to arterial hypertension, require more antihypertensive medications, and have an increased risk of treatment-resistant arterial hypertension. Obesity-induced neurohumoral activation appears to be involved. The association between obesity and hypertension shows large inter-individual variability, likely through genetic mechanisms. Obesity affects overall cardiovascular and metabolic risk; yet, the relationship between obesity and cardiovascular risk is complex and not sufficiently addressed in clinical guidelines. The epidemiological observation that obesity may be protective in patients with established cardiovascular disease is difficult to translate into clinical experience and practice. Weight loss is often recommended as a means to lower blood pressure. However, current hypertension guidelines do not provide evidence-based guidance on how to institute weight loss. In fact, weight loss influences on blood pressure may be overestimated. Nevertheless, weight loss through bariatric surgery appears to decrease cardiovascular risk in severely obese patients. Eventually, most obese hypertensive patients will require antihypertensive medications. Data from large-scale studies with hard clinical endpoints on...Continue Reading

References

Jan 1, 1982·Contributions to Nephrology·F H MesserliE D Frohlich
Feb 15, 1994·American Journal of Epidemiology·J HeG Q He
Jan 24, 1994·Archives of Internal Medicine·J L CarsonR E Brolin
Aug 28, 1993·BMJ : British Medical Journal·R E SchmiederH Rüddel
May 5, 1999·JAMA : the Journal of the American Medical Association·R BenderM Berger
Aug 31, 1999·Journal of Hypertension·M S RumantirM D Esler
Nov 5, 1999·JAMA : the Journal of the American Medical Association·A MustW H Dietz
Feb 24, 2001·Annals of Internal Medicine·V J StevensUNKNOWN Trials for the Hypertension Prevention Research Group
Nov 29, 2001·Journal of Hypertension·P StrazzulloF Galletti
Nov 29, 2001·Journal of Hypertension·A G LoganT D Bradley
Jan 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S DollV Wietlisbach
Apr 3, 2002·The Journal of Clinical Hypertension·William C CushmanRobert K Zeldin
Aug 28, 2002·Archives of Internal Medicine·Peter W F WilsonWilliam B Kannel
Nov 1, 2002·Journal of Hypertension·George BakrisUNKNOWN orlistat and resistant hypertension investigators
Nov 6, 2002·Circulation·Andreas L BirkenfeldJens Jordan
Apr 26, 2003·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Jan 21, 2004·Hypertension·Theodore L Goodfriend, David A Calhoun
Oct 16, 2004·American Journal of Hypertension·Peter BramlageArya M Sharma
Oct 16, 2004·American Journal of Hypertension·Jingzhong DingTamara B Harris
Nov 13, 2004·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN GEMINI Investigators
Dec 8, 2004·Hypertension·Kamal RahmouniAllyn L Mark
Jan 5, 2005·Hypertension·Stefan EngeliArya M Sharma
Feb 3, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J JordanA M Sharma
Sep 15, 2005·Current Hypertension Reports·Francesco DentaliJames D Douketis
Nov 18, 2005·The New England Journal of Medicine·Thomas A WaddenAlbert J Stunkard
Nov 18, 2005·The New England Journal of Medicine·Jean-Pierre DesprésUNKNOWN Rimonabant in Obesity-Lipids Study Group
Feb 16, 2006·JAMA : the Journal of the American Medical Association·F Xavier Pi-SunyerUNKNOWN RIO-North America Study Group
May 9, 2006·Clinical Pharmacology and Therapeutics·Karsten HeusserJens Jordan
Sep 19, 2006·The New England Journal of Medicine·UNKNOWN DREAM Trial InvestigatorsRury R Holman

❮ Previous
Next ❯

Citations

Aug 13, 2013·Current Hypertension Reports·Stefan Engeli, Jens Jordan
Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Srividya Kidambi, Theodore A Kotchen
Aug 21, 2013·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Franco VeglioMassimo Volpe
Sep 13, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tetsuo NishikawaYoko Matsuzawa
Sep 13, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Sven Haufe, Jens Jordan
Aug 12, 2015·European Heart Journal·Stefano F RimoldiUrs Scherrer
Nov 6, 2012·Expert Opinion on Pharmacotherapy·Guido Grassi
Jun 20, 2013·Blood Pressure·UNKNOWN Task Force for the management of arterial hypertension of the European Society of Hypertension, UNKNOWN Task Force for the management of arterial hypertension of the European Society of Cardiology
Nov 5, 2016·Eating and Weight Disorders : EWD·Alessandro Lechi
Feb 28, 2017·Blood Pressure Monitoring·Ilargi Gorostegi-AnduagaSara Maldonado-Martín
Apr 1, 2015·Clinical Obesity·N Finer
Nov 26, 2016·The Medical Clinics of North America·Dinko Susic, Jasmina Varagic
Nov 5, 2017·Current Obesity Reports·Catherine M KotzCharles J Billington
Apr 16, 2014·Nature Reviews. Endocrinology·Vincent G DeMarcoJames R Sowers
Jun 8, 2013·Journal of the American Heart Association·Giovanni de SimoneMary J Roman
Aug 1, 2015·Chinese Medical Journal·Ning-Ling SunXue-Wang Li
Aug 31, 2018·European Heart Journal·Bryan WilliamsUNKNOWN ESC Scientific Document Group
Feb 5, 2019·Diabetes/metabolism Research and Reviews·Christian Ortega-LoubonRicardo Correa
Feb 6, 2013·Nature Reviews. Endocrinology·Guido Grassi, Giuseppe Mancia
Mar 21, 2013·Obesity·Marie-Éve LeblancPaul Poirier
Jun 11, 2014·Current Opinion in Nephrology and Hypertension·Stefan Engeli, Jens Jordan
Aug 15, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Giuseppe MurdoloPaolo Vedecchia
Oct 2, 2019·International Journal of Clinical Practice·Jing LiuYong Huo
Feb 25, 2020·Obesity·José Carlos Fernández-GarcíaUNKNOWN PREDIMED-Plus Investigators
Oct 6, 2017·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Qian YangKaijuan Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.